Aggarwal S, Thareja S, Verma A, Bhardwaj TR, Kumar M
AMA: Use of BMI alone is an imperfect clinical measure
Tirzepatide activates both GLP-1 and GIP receptors, which in trials has produced greater average weight loss than GLP-1 alone
The class now includes three types: GLP-1 agonists: Activate the GLP-1 receptor only (semaglutide, liraglutide, exenatide, dulaglutide, lixisenatide, orforglipron) Dual GLP-1/GIP agonists: Activate both GLP-1 and GIP receptors (tirzepatide) Triple agonists (investigational): Activate GLP-1, GIP, and glucagon receptors (retatrutide, in Phase 3 trials) GLP-1 Medications Compared: Full Comparison Chart Here's every GLP-1 medication currently FDA-approved, with the data you actually need to compare them side by side
Third-party tested COA available per batch Ships within 48 hours discreet packaging Free shipping over 150 About BPC-157 + TB-500 The BPC-157 + TB-500 stack brings together two of the most extensively researched regenerative peptides within the scientific community
D.BaffesG